To confirm the effect of GC and leflunomide on neutrophil phenotype, we measured neutrophil CD62L and CD11b expression in peripheral blood of 25 GCA patients who responded to therapy, at T0 and at weeks 1, 4, 12, 24, and 48 of follow-up. This evidence concerns the gene ITGAM and temporal arteritis.